The evidence supporting platelet hyperactivity in individuals with type 1 diabetes is largely limited to data from early aggregation studies ([5–7] and evidence of elevated expression of surface P-selectin, as well as increased circulating levels of platelet–monocyte aggregates [8]. The gene discussed is SELP; the disease is type 1 diabetes mellitus.